The latest closing stock price for InMed Pharmaceuticals as of January 31, 2025 is 3.08.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2020 would have $-962 today, roughly -1 times their original investment - a -55.88% compound annual growth rate over 4 years.
The all-time high InMed Pharmaceuticals stock closing price was 133.75 on February 11, 2021.
The InMed Pharmaceuticals 52-week high stock price is 8.27, which is 168.5% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 0.12, which is 96.1% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 1.17.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2020 would have $-962 today, roughly -1 times their original investment - a -55.88% compound annual growth rate over 4 years.
The all-time high InMed Pharmaceuticals stock closing price was 133.75 on February 11, 2021.
The InMed Pharmaceuticals 52-week high stock price is 8.27, which is 168.5% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 0.12, which is 96.1% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 1.17.